This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
RM Carney , KE Freedland , GE Miller , AS Jaffe (2002). Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. Journal of Psychosomatic Research 53, 897–902.
JM Cyranowski , AL Marsland , JT Bromberger , TL Whiteside , Y Chang , KA Matthews (2007). Depressive symptoms and production of proinflammatory cytokines by peripheral blood mononuclear cells stimulated in vitro. Brain, Behavior, and Immunity 21, 229–237.
A Danese , CA Pariante , A Caspi , A Taylor , R Poulton (2007). Childhood maltreatment predicts adult inflammation in a life-course study. Proceedings of the National Academy of Sciences USA 104, 1319–1324.
J Danesh , JG Wheeler , GM Hirschfield , S Eda , G Eiriksdottir , A Rumley , GD Lowe , MB Pepys , V Gudnason (2004). C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. New England Journal of Medicine 350, 1387–1397.
AN Dentino , CF Pieper , MK Rao , MS Currie , T Harris , DG Blazer , HJ Cohen (1999). Association of interleukin-6 and other biologic variables with depression in older people living in the community. Journal of the American Geriatrics Society 47, 6–11.
JK Kiecolt-Glaser , L McGuire , TF Robles , R Glaser (2002). Emotions, morbidity, and mortality: new perspectives from psychoneuroimmunology. Annual Review of Psychology 53, 83–107.
A Kingman , G Zion (1994). Some power considerations when deciding to use transformations. Statistics in Medicine 13, 769–783.
M Kumari , J Head , M Marmot (2004). Prospective study of social and other risk factors for incidence of type 2 diabetes in the Whitehall II study. Archives of Internal Medicine 164, 1873–1880.
HK Kuo , CJ Yen , CH Chang , CK Kuo , JH Chen , F Sorond (2005). Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurology 4, 371–380.
CY Li , FC Sung (1999). A review of the healthy worker effect in occupational epidemiology. Occupational Medicine 49, 225–229.
T Liukkonen , S Silvennoinen-Kassinen , J Jokelainen , P Rasanen , M Leinonen , VB Meyer-Rochow , M Timonen (2006). The association between C-reactive protein levels and depression: results from the northern Finland 1966 birth cohort study. Biological Psychiatry 60, 825–830.
M Maes , E Vandoolaeghe , R Ranjan , E Bosmans , R Bergmans , R Desnyder (1995 b). Increased serum interleukin-1-receptor-antagonist concentrations in major depression. Journal of Affective Disorders 36, 29–36.
GB Mancini , B Dahlof , J Diez (2004). Surrogate markers for cardiovascular disease: structural markers. Circulation 109 (Suppl. 1), IV22–IV30.
M Marmot , E Brunner (2005). Cohort profile: the Whitehall II study. International Journal of Epidemiology 34, 251–256.
MG Marmot , GD Smith , S Stansfeld , C Patel , F North , J Head , I White , E Brunner , A Feeney (1991). Health inequalities among British civil servants: the Whitehall II study. Lancet 337, 1387–1393.
GL Myers , N Rifai , RP Tracy , WL Roberts , RW Alexander , LM Biasucci , JD Catravas , TG Cole , GR Cooper , BV Khan , MM Kimberly , EA Stein , KA Taubert , GR Warnick , PP Waymack (2004). CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the laboratory science discussion group. Circulation 110, e545–e549.
A Nicholson , R Fuhrer , M Marmot (2005). Psychological distress as a predictor of CHD events in men: the effect of persistence and components of risk. Psychosomatic Medicine 67, 522–530.
TW Pace , TC Mletzko , O Alagbe , DL Musselman , CB Nemeroff , AH Miller , CM Heim (2006). Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. American Journal of Psychiatry 163, 1630–1633.
AD Pradhan , JE Manson , N Rifai , JE Buring , PM Ridker (2001). C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. Journal of the American Medical Association 286, 327–334.
RB Sothern , B Roitman-Johnson , EL Kanabrocki , JG Yager , MM Roodell , JA Weatherbee , MR Young , BM Nenchausky , LE Scheving (1995). Circadian characteristics of circulating interleukin-6 in men. Journal of Allergy and Clinical Immunology 95, 1029–1035.
SA Stansfeld , J Head , R Fuhrer , J Wardle , V Cattell (2003). Social inequalities in depressive symptoms and physical functioning in the Whitehall II study: exploring a common cause explanation. Journal of Epidemiology and Community Health 57, 361–367.
M Woodward , A Rumley , GD Lowe , H Tunstall-Pedoe (2003). C-reactive protein: associations with haematological variables, cardiovascular risk factors and prevalent cardiovascular disease. British Journal of Haematology 122, 135–141.
M Woodward , A Rumley , H Tunstall-Pedoe , GD Lowe (1999). Associations of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular disease. British Journal of Haematology 104, 246–257.
K Yaffe , A Kanaya , K Lindquist , EM Simonsick , T Harris , RI Shorr , FA Tylavsky , AB Newman (2004). The metabolic syndrome, inflammation, and risk of cognitive decline. Journal of the American Medical Association 292, 2237–2242.